Melanin concentrating hormone (MCH) is a hypothalamic neuropeptide with a well-39 characterised role in energy homeostasis and emergent roles in diverse physiologic 40 functions such as arousal, mood and reproduction. Work to date has predominantly 41 focused on its hypothalamic functions using animal models however little attention 42 has been paid to its role in circulation in humans. The aims of this study were to a) 43 Blood samples from 231 subjects were taken to establish a 48 reference range of 19.5-55.4 pg/ml for fasting MCH concentrations. There were no 49 significant differences between male and female fasting MCH concentrations 50 however there were correlations between MCH concentrations and BMI in males and 51 females with excess fat (p<0.001 and p=0.020) and between MCH concentrations 52 and fat mass in females with excess fat (p=0.038). Plasma MCH concentrations rose 53 significantly after feeding in a group of older individuals (n=50, males p=0.006, 54 females p=0.023). There were no robust significant correlations between fasting or 55 post-prandial MCH and resting metabolic rate, plasma glucose, insulin or leptin 56 concentrations although there were correlations between circulating MCH and leptin 57 concentrations in older individuals (p=0.029). These results indicate that the role of 58 circulating MCH may not be reflective of its regulatory hypothalamic role. 59
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Page 7 UK) was added following the manufacturer's instructions; that is, 0.1 ml SacCel were 137 added to each tube (except total counts), left for 30 minutes at room temperature 138 and then 1 ml deionized water was added before all tubes were centrifuged at 1000 139 rpm and 4°C for 10 min. The supernatant was aspirated and the resultant pellet was 140 counted for 1 minute on a gamma counter. Data were analysed using AssayZap 141 (Biosoft, Cambridge, UK). with EDTA (1:9 dilution) with/without purified MCH and subjected to RP-HPLC. 155
Fractions were collected at 1 minute intervals and the aliquots analysed for MCH by 156
RIA. 157 158
Circulating MCH 159
Subjects 160
The experiments involving human subjects were approved by the University ofWestminster's Ethics Sub-Committee. Each subject gave full informed consent. 162
Fasting blood samples were taken from all subjects between 8 and 11.30 am. 163
164
Cross-sectional study: Fasting venous blood samples were collected from 135 165 females and 96 males. Weight to the nearest 0.1 kg, height to the nearest 0.1 cm, 166 waist and hip circumference were measured. Total fat and lean body mass were 167 measured by air displacement plethysmography (BodPod: Body Composition 168
Tracking System, Version 4.1; Life Measurement Instruments, Concord, CA, USA). 169
All venous blood samples were collected in EDTA vacutainers and plasma recovered 170 after centrifugation. Plasma was stored at -20˚C until MCH concentrations were 171 determined by RIA (intra-and inter-assay CVs were 2.4% and 3.7%, respectively). 172
173
Intervention studies: Two cohorts were recruited. Cohort A) 18-30 years: 21 females 174 and 11 males. The inclusion criteria for females were: pre-menopausal (however the 175 stage of the menstrual cycle was not recorded); non-hormonal contraceptive using; 176 and a body mass index (BMI) of ≤24.9. The inclusion criterion for males was BMI of 177 ≤24.9. Cohort B) Over 40 years: a) lean individuals (11 females and 11 males) and 178 b) those with excess body fat (13 females and 15 males). Lean (L) was defined as 179 <31 % body fat in females and <21 % body fat in males. Excess body fat (E) was 180 defined as ≥31 % body fat in females and ≥21 % body fat in males (ACSM, 1996) . 181
The inclusion criterion for both males and females was that they should be over 40 182 years of age. In both cohorts, those on medication(s) for chronic illness or known to 183 cause hypo-or hyperglycaemia or affect metabolic rate and females who were 184 pregnant, lactating or recently lactating were excluded. Millipore, USA; intra-assay CV: 8.3% at 4.9 ng/ml; 3.4% at 25.6 ng/ml) and insulin 195 (DSL-1600, Diagnostic Systems Inc., USA; intra-assay CV: 8.3% at 4.8 µIU/ml; 6.4% 196 at 54.6 µIU/ml). All samples for each cohort were assayed for each hormone in a 197 single assay. The fingerprick blood samples were immediately analysed for blood 198 glucose concentrations using the Hemocue Glucose 201+ Analyser (Hemocue AB, 199
Sweden; intra-assay CV <1.8%). (ML)=body fat % <21%; male excess fat (ME)=body fat % ≥21%; female lean 212 (FL)=body fat % <31%; female excess fat (FE)=body fat % ≥31% (ACSM, 1996) . 213
Subjects were sub-divided by body composition after data collection for the cross-214 sectional and both intervention studies. 215
216
Inter-gender differences between anthropometric characteristics and circulating 217 
RIA development and validation
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The gold standard method for the detection of MCH is RP-HPLC and MS hence this 236
method was used to demonstrate that MCH is present in plasma. Using RP-HPLC, 237 the retention time for purified MCH was between 21 and 28 minutes (Figure 1a) . It 238 was predicted that product ions of m/z 796 and 2 of m/z 1194 would be generated 239 specifically for MCH and these were detected at the corresponding elution times 240 when either purified MCH or human plasma samples were analysed by MS (Figure  241 A sensitive and specific RIA for the quantifiable measurement of MCH in human 321 plasma has been successfully developed. To confirm that MCH is detectable and 322 measurable in human plasma cross-validation was performed by RP-HPLC and MS. 323
A peak was detected between 21 and 28 minutes when plasma was run through the 324 HPLC column which corresponds to the elution time of purified MCH.
Additionally, 325 when human plasma was subject to MS, product ions of identical mass to those 326 generated by purified MCH were observed. Immunoreactive MCH was detected by 327 RIA only in the eluates collected between 18 and 28 minutes of either purified MCH 328 or human plasma. In the RIA, the only molecule assessed showing evidence of 329 cross-reactivity was NEI-MCH, though only at supra-physiological concentrations. 330
Currently there is little evidence to suggest that NEI-MCH circulates therefore at 331 physiological concentrations this assay is specific for MCH. Furthermore, parallelism 332 of the dilution curves of plasma to the standard curve confirmed that other plasma 333 components have no adverse effects on the curve. Plasma MCH retained stability 334 under various conditions including freeze-thaw cycles and being left at room There were no differences between male and female fasting circulating MCH 385 concentrations. In this respect, our results agree with those of Gavrila and 386 colleagues (Gavrila et al., 2005) .
Age-related changes in body composition did not 387 appear to impact on circulating MCH concentrations since there were no differences 388 in circulating MCH concentrations between groups when all subjects in the cross-389 sectional study were categorized by gender, age (≤30 years, 31-39 years and ≥40 390 years) and % body fat (male lean=<21 %; male excess fat=≥ 21%; female lean=<31 391 %; female excess fat=≥31%). Nor was there a significant correlation between age 392 and absolute circulating MCH concentrations. However in the intervention studies 393 an effect of age was observed, both in fasting MCH concentrations which were 394 greater in the younger group compared to the older group and in the post-prandial 395 response (compare Figures 3 and 4) . 396
397
In the older group circulating MCH concentrations rose significantly during the 2 hour 398 post-prandial sampling period in males and females, and in both lean individuals and 399 those with excess fat. In the younger group, post-prandial circulating MCH 400 concentrations did not change significantly. In both groups, post-ingestive circulating 401 leptin concentrations declined significantly. Whether or not this was related to the 402 meal, MCH concentrations or the morning nadir of leptin requires qualification (Sinha 403 et al., 1996) . In the lipostatic model of energy homeostasis (for review see Woods, observed. There does however appear to be some differential regulation in the 480 presence of a combination of gender and adiposity which is variable depending on 481 the population under examination. Hence, in the subjects studied here circulating 482 MCH is not a marker of energy homeostasis, contrary to the suggestion of Gavrila 483 and colleagues (2005) . Rather our results suggest that circulating MCH may not
